{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:07:23Z","timestamp":1779530843293,"version":"3.53.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100008522","name":"University of Illinois at Chicago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008522","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015131","name":"Foundation for Sarcoidosis Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015131","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s40744-026-00838-1","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:44:04Z","timestamp":1774460644000},"page":"451-465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outdated Frameworks, Missed Opportunities: A Call for Establishing Classification Criteria for Patients with Sarcoidosis"],"prefix":"10.1007","volume":"13","author":[{"given":"Nadera J.","family":"Sweiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Dominati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricha","family":"Shivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Ladouceur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"838_CR1","doi-asserted-by":"crossref","unstructured":"Miedema JR, Bonella F, Buschulte K, et al. Sarcoidosis: a state-of-the-art review. Eur Respir J. 2026;67(2):2501324.","DOI":"10.1183\/13993003.01324-2025"},{"key":"838_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2024.101949","volume":"37","author":"M Aringer","year":"2023","unstructured":"Aringer M, Toro-Dom\u00ednguez D, Alarc\u00f3n-Riquelme ME. Classification of systemic lupus erythematosus: from the development of classification criteria to a new taxonomy? Best Pract Res Clin Rheumatol. 2023;37:101949.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"838_CR3","volume":"42","author":"RP Baughman","year":"2025","unstructured":"Baughman RP, Lower EE, Culver DA, Judson MA, Wells AU. WASOG clinical trial endpoint task force: executive summary. Sarcoidosis Vasc Diffuse Lung Dis. 2025;42:17859.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"838_CR4","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2026 GOLD COPD Report. https:\/\/goldcopd.org\/2026-gold-report-and-pocket-guide\/. Accessed 27 Jan 2026."},{"key":"838_CR5","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/acr.22583","volume":"67","author":"R Aggarwal","year":"2015","unstructured":"Aggarwal R, Ringold S, Khanna D, et al. Distinctions between diagnostic and classification criteria. Arthritis Care Res. 2015;67:891\u20137.","journal-title":"Arthritis Care Res"},{"key":"838_CR6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.iac.2012.08.005","volume":"32","author":"DA Culver","year":"2012","unstructured":"Culver DA. Sarcoidosis. Immunol Allergy Clin North Am. 2012;32:487\u2013511.","journal-title":"Immunol Allergy Clin North Am"},{"key":"838_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.berh.2016.07.001","volume":"30","author":"AM Yee","year":"2016","unstructured":"Yee AM. Sarcoidosis: rheumatology perspective. Best Pract Res Clin Rheumatol. 2016;30:334\u201356.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"838_CR8","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/bjr\/tqaf118","volume":"98","author":"H Abbas","year":"2025","unstructured":"Abbas H, Kokosi M, Sivarasan N. Phenotyping pulmonary sarcoidosis. Br J Radiol. 2025;98:1188\u201396.","journal-title":"Br J Radiol"},{"issue":"1","key":"838_CR9","first-page":"tzaf017","volume":"7","author":"J Van Woensel","year":"2025","unstructured":"Van Woensel J, Krdzalic J, de Jaegere T, et al. Radiological phenotypes in pulmonary sarcoidosis: a reliability study of newly defined high-resolution computer tomography phenotypes. BJR Open. 2025;7(1):tzaf017.","journal-title":"BJR Open"},{"key":"838_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S2213-2600(23)00267-9","volume":"12","author":"SR Desai","year":"2024","unstructured":"Desai SR, Sivarasan N, Johannson KA, et al. High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study. Lancet Respir Med. 2024;12:409\u201318.","journal-title":"Lancet Respir Med"},{"key":"838_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1053\/j.ro.2025.02.007","volume":"60","author":"SG Roy","year":"2025","unstructured":"Roy SG, Digumarthy SR. Imaging evaluation of mediastinal and hilar lymphadenopathy: approach, classification, and differential diagnosis. Semin Roentgenol. 2025;60:105\u201322.","journal-title":"Semin Roentgenol"},{"key":"838_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0002-9343(52)90208-8","volume":"12","author":"LE Siltzbach","year":"1952","unstructured":"Siltzbach LE. Effects of cortisone in sarcoidosis; a study of thirteen patients. Am J Med. 1952;12:139\u201360.","journal-title":"Am J Med"},{"key":"838_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJM195102082440606","volume":"244","author":"M Sones","year":"1951","unstructured":"Sones M, Israel HL, Dratman MB, Frank JH. Effect of cortisone in sarcoidosis. N Engl J Med. 1951;244:209\u201313.","journal-title":"N Engl J Med"},{"key":"838_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.991783","volume":"9","author":"ON Obi","year":"2022","unstructured":"Obi ON, Saketkoo LA, Russell A-M, Baughman RP. Sarcoidosis: updates on therapeutic drug trials and novel treatment approaches. Front Med. 2022;9:991783.","journal-title":"Front Med"},{"key":"838_CR15","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","volume":"201","author":"ED Crouser","year":"2020","unstructured":"Crouser ED, Maier LA, Baughman RP, et al. Diagnosis and detection of sarcoidosis an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;201:e26\u201351.","journal-title":"Am J Respir Crit Care Med"},{"key":"838_CR16","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","volume":"83","author":"F Terasaki","year":"2019","unstructured":"Terasaki F, Azuma A, Anzai T, et al. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis \u2014 digest version. Circ J. 2019;83:2329\u201388.","journal-title":"Circ J"},{"key":"838_CR17","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1136\/bjophthalmol-2018-313356","volume":"103","author":"M Mochizuki","year":"2019","unstructured":"Mochizuki M, Smith JR, Takase H, Kaburaki T, Acharya NR, Rao NA. Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol. 2019;103:1418\u201322.","journal-title":"Br J Ophthalmol"},{"key":"838_CR18","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1001\/jamaneurol.2018.2295","volume":"75","author":"BJ Stern","year":"2018","unstructured":"Stern BJ, Royal W 3rd, Gelfand JM, et al. Definition and consensus diagnostic criteria for neurosarcoidosis: from the Neurosarcoidosis Consortium Consensus Group. JAMA Neurol. 2018;75:1546\u201353.","journal-title":"JAMA Neurol"},{"key":"838_CR19","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.chest.2018.05.003","volume":"154","author":"AN Bickett","year":"2018","unstructured":"Bickett AN, Lower EE, Baughman RP. Sarcoidosis diagnostic score: a systematic evaluation to enhance the diagnosis of sarcoidosis. Chest. 2018;154:1052\u201360.","journal-title":"Chest"},{"key":"838_CR20","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s12350-017-0978-9","volume":"24","author":"P Chareonthaitawee","year":"2017","unstructured":"Chareonthaitawee P, Beanlands RS, Chen W, et al. Joint SNMMI-ASNC expert consensus document on the role of F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Cardiol. 2017;24:1741\u201358.","journal-title":"J Nucl Cardiol"},{"key":"838_CR21","first-page":"19","volume":"31","author":"MA Judson","year":"2014","unstructured":"Judson MA, Costabel U, Drent M, et al. The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31:19\u201327.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"838_CR22","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","volume":"11","author":"DH Birnie","year":"2014","unstructured":"Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305\u201323.","journal-title":"Heart Rhythm"},{"key":"838_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/09273940902818861","volume":"17","author":"CP Herbort","year":"2009","unstructured":"Herbort CP, Rao NA, Mochizuki M. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17:160\u20139.","journal-title":"Ocul Immunol Inflamm"},{"key":"838_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/09273940802051100","volume":"16","author":"Y Asukata","year":"2008","unstructured":"Asukata Y, Ishihara M, Hasumi Y, et al. Guidelines for the diagnosis of ocular sarcoidosis. Ocul Immunol Inflamm. 2008;16:77\u201381.","journal-title":"Ocul Immunol Inflamm"},{"key":"838_CR25","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.mehy.2006.09.041","volume":"68","author":"MA Judson","year":"2007","unstructured":"Judson MA. A proposed solution to the clinical assessment of sarcoidosis: the sarcoidosis three-dimensional assessment instrument (STAI). Med Hypotheses. 2007;68:1080\u20137.","journal-title":"Med Hypotheses"},{"key":"838_CR26","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1253\/circj.CJ-88-0008","volume":"75","author":"JCS Working Group","year":"2011","unstructured":"JCS Working Group. Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version. Circ J. 2011;75:734\u201343.","journal-title":"Circ J"},{"key":"838_CR27","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","author":"Statement on sarcoidosis","year":"1999","unstructured":"Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736\u201355.","journal-title":"Am J Respir Crit Care Med"},{"key":"838_CR28","first-page":"75","volume":"16","author":"MA Judson","year":"1999","unstructured":"Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H Jr. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16:75\u201386.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"838_CR29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1080\/14779072.2023.2266367","volume":"21","author":"S Kurashima","year":"2023","unstructured":"Kurashima S, Kitai T, Xanthopoulos A, Skoularigis J, Triposkiadis F, Izumi C. Diagnosis of cardiac sarcoidosis: histological evidence vs. imaging. Expert Rev Cardiovasc Ther. 2023;21:693\u2013702.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"6","key":"838_CR30","doi-asserted-by":"publisher","first-page":"e027971","DOI":"10.1161\/JAHA.122.027971","volume":"12","author":"L Ueberham","year":"2023","unstructured":"Ueberham L, Hagendorff A, Klingel K, et al. Pathophysiological gaps, diagnostic challenges, and uncertainties in cardiac sarcoidosis. J Am Heart Assoc. 2023;12(6):e027971.","journal-title":"J Am Heart Assoc"},{"key":"838_CR31","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s12350-020-02359-y","volume":"29","author":"M Okune","year":"2022","unstructured":"Okune M, Yasuda M, Soejima N, et al. Diagnostic utility of fusion 18F-fluorodeoxyglucose positron emission tomography\/cardiac magnetic resonance imaging in cardiac sarcoidosis. J Nucl Cardiol. 2022;29:753\u201364.","journal-title":"J Nucl Cardiol"},{"key":"838_CR32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.amjcard.2023.07.123","volume":"204","author":"G Santulli","year":"2023","unstructured":"Santulli G. Cardiac sarcoidosis: updated insights on epidemiology and diagnostic criteria. Am J Cardiol. 2023;204:425\u20137.","journal-title":"Am J Cardiol"},{"issue":"1","key":"838_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33631-z","volume":"13","author":"SG Berntsson","year":"2023","unstructured":"Berntsson SG, Elmgren A, Gudjonsson O, Grabowska A, Landtblom AM, Moraes-Fontes MF. A comprehensive diagnostic approach in suspected neurosarcoidosis. Sci Rep. 2023;13(1):6539.","journal-title":"Sci Rep"},{"key":"838_CR34","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1080\/14737175.2022.2108705","volume":"22","author":"P Ungprasert","year":"2022","unstructured":"Ungprasert P, Sukpornchairak P, Moss BP, Ribeiro Neto ML, Culver DA. Neurosarcoidosis: an update on diagnosis and therapy. Expert Rev Neurother. 2022;22:695\u2013705.","journal-title":"Expert Rev Neurother"},{"key":"838_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2022.577871","volume":"368","author":"P Barreras","year":"2022","unstructured":"Barreras P, Stern BJ. Clinical features and diagnosis of neurosarcoidosis. Review. J Neuroimmunol. 2022;368:577871.","journal-title":"J Neuroimmunol"},{"key":"838_CR36","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ajo.2021.03.047","volume":"228","author":"Standardization of Uveitis Nomenclature (SUN) Working Group","year":"2021","unstructured":"Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for sarcoidosis-associated uveitis. Am J Ophthalmol. 2021;228:220\u201330.","journal-title":"Am J Ophthalmol"},{"key":"838_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2024.103288","author":"LJ Harper","year":"2024","unstructured":"Harper LJ, Farver CF, Yadav R, Culver DA. A framework for exclusion of alternative diagnoses in sarcoidosis. J Autoimmun. 2024. https:\/\/doi.org\/10.1016\/j.jaut.2024.103288.","journal-title":"J Autoimmun"},{"key":"838_CR38","doi-asserted-by":"crossref","unstructured":"Jeny F. Validation of the Sarcoidosis Diagnostic Score in a multinational study. European-Respiratory-Society (ERS) International Congress; Madrid, Spain. Eur Respir J. 2019;OA5155.","DOI":"10.1183\/13993003.congress-2019.OA5155"},{"key":"838_CR39","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1513\/AnnalsATS.202206-529OC","volume":"20","author":"F Jeny","year":"2023","unstructured":"Jeny F, Vucinic V, Zhou Y, et al. Validation of the sarcoidosis diagnostic score in a multicontinental study. Ann Am Thorac Soc. 2023;20:371\u201380.","journal-title":"Ann Am Thorac Soc"},{"issue":"7","key":"838_CR40","volume":"12","author":"OD Ogbue","year":"2020","unstructured":"Ogbue OD, Malhotra P, Akku R, Jayaprakash TP, Khan S. Biologic therapies in sarcoidosis and uveitis: a review. Cureus. 2020;12(7):e9057.","journal-title":"Cureus"},{"key":"838_CR41","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1513\/AnnalsATS.201503-172OT","volume":"12","author":"DR Moller","year":"2015","unstructured":"Moller DR, Koth LL, Maier LA, et al. Rationale and design of the genomic research in alpha-1 antitrypsin deficiency and sarcoidosis (GRADS) study. Sarcoidosis protocol. Ann Am Thorac Soc. 2015;12:1561\u201371.","journal-title":"Ann Am Thorac Soc"},{"key":"838_CR42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","volume":"79","author":"ZS Wallace","year":"2020","unstructured":"Wallace ZS, Naden RP, Chari S, et al. The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020;79:77\u201387.","journal-title":"Ann Rheum Dis"},{"key":"838_CR43","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, et al. Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737\u201347.","journal-title":"Arthritis Rheum"},{"key":"838_CR44","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71:1400\u201312.","journal-title":"Arthritis Rheumatol"},{"key":"838_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33631-z","author":"SG Berntsson","year":"2023","unstructured":"Berntsson SG, Elmgren A, Gudjonsson O, et al. A comprehensive diagnostic approach in suspected neurosarcoidosis. Sci Rep. 2023. https:\/\/doi.org\/10.1038\/s41598-023-33631-z.","journal-title":"Sci Rep"},{"key":"838_CR46","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11882-023-01092-z","volume":"23","author":"J Shen","year":"2023","unstructured":"Shen J, Lackey E, Shah S. Neurosarcoidosis: diagnostic challenges and mimics a review. Curr Allergy Asthma Rep. 2023;23:399\u2013410.","journal-title":"Curr Allergy Asthma Rep"},{"key":"838_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-025-04221-w","author":"S Mellor-Pita","year":"2026","unstructured":"Mellor-Pita S, Moreno-Torres V, Esteban-Sampedro J, et al. Impact of comorbidities and organ damage on hospital admissions and mortality in patients with sarcoidosis: an observational study from the Spanish National Registry. Intern Emerg Med. 2026. https:\/\/doi.org\/10.1007\/s11739-025-04221-w.","journal-title":"Intern Emerg Med"},{"key":"838_CR48","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/crj.12398","volume":"11","author":"A Nowi\u0144ski","year":"2017","unstructured":"Nowi\u0144ski A, Pu\u015bci\u0144ska E, Goljan A, et al. The influence of comorbidities on mortality in sarcoidosis: a observational prospective cohort study. Clin Respir J. 2017;11:648\u201356.","journal-title":"Clin Respir J"},{"key":"838_CR49","first-page":"104","volume":"37","author":"J Larsson","year":"2020","unstructured":"Larsson J, Graff P, Bryngelsson IL, Vihlborg P. Sarcoidosis and increased risk of comorbidities and mortality in Sweden. Sarcoidosis Vasc Diffuse Lung Dis. 2020;37:104\u201335.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"838_CR50","volume":"41","author":"V Jaiswal","year":"2022","unstructured":"Jaiswal V, Peng Ang S, Sarfraz Z, et al. Association between sarcoidosis and cardiovascular outcomes: a systematic review and meta-analysis. Int J Cardiol Heart Vasc. 2022;41:101073.","journal-title":"Int J Cardiol Heart Vasc"},{"key":"838_CR51","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jacc.2020.06.038","volume":"76","author":"A Yafasova","year":"2020","unstructured":"Yafasova A, Fosb\u00f8l EL, Schou M, et al. Long-term adverse cardiac outcomes in patients with sarcoidosis. J Am Coll Cardiol. 2020;76:767\u201377.","journal-title":"J Am Coll Cardiol"},{"key":"838_CR52","unstructured":"ACR-Endorsed Criteria. https:\/\/rheumatology.org\/criteria. Accessed 25 Aug 2025."}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-026-00838-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-026-00838-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-026-00838-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:02:33Z","timestamp":1779530553000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-026-00838-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["838"],"URL":"https:\/\/doi.org\/10.1007\/s40744-026-00838-1","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nadera J. Sweiss, Arnaud Dominati, Mary McGowan, Tricha Shivas, Alexandra Ladouceur, Israel Rubinstein, and Murray Baron have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not include any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}